Amphastar Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $57.3M | $23.4M | $33.9M | $20.5M |
| FY2021 | $98.0M | $70.5M | $27.5M | $18.7M |
| FY2022 | $89.2M | $65.1M | $24.0M | $17.9M |
| FY2023 | $183.5M | $145.3M | $38.2M | $20.2M |
| FY2024 | $213.4M | $172.3M | $41.0M | $24.4M |